Literature DB >> 11370374

Ultrasonic attenuation in human calcaneus from 0.2 to 1.7 MHz.

K A Wear1.   

Abstract

Ultrasonic attenuation has been demonstrated to be a useful measurement in the diagnosis of osteoporosis. Most studies have employed ultrasound in a range of frequencies from about 200 kHz-300 kHz to 600 kHz-1 MHz, and many have assumed a linear dependence of attenuation on frequency. In order to investigate the attenuation properties of human calcaneus at higher frequencies, 16 defatted human calcanea were interrogated in vitro using two matched pairs of transducers with center frequencies of 500 kHz and 2.25 MHz. The linear dependence of attenuation on frequency seems to extend up to at least 1.7 MHz. The correlation between attenuation coefficient and frequency from 400 kHz to 1.7 MHz was r = 0.999 (95% confidence interval, CI, = 0.998-1.00). The measurements suggest that some deviations from linear frequency dependence of attenuation may occur at lower frequencies (below 400 kHz), however.

Entities:  

Mesh:

Year:  2001        PMID: 11370374      PMCID: PMC9137354          DOI: 10.1109/58.911743

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   3.267


  38 in total

1.  Low-megahertz ultrasonic properties of bovine cancellous bone.

Authors:  B K Hoffmeister; S A Whitten; J Y Rho
Journal:  Bone       Date:  2000-06       Impact factor: 4.398

2.  Frequency dependence of ultrasonic backscatter from human trabecular bone: theory and experiment.

Authors:  K A Wear
Journal:  J Acoust Soc Am       Date:  1999-12       Impact factor: 1.840

3.  Assessment of the relationship between broadband ultrasound attenuation and bone mineral density at the calcaneus using BUA imaging and DXA.

Authors:  C Chappard; P Laugier; B Fournier; C Roux; G Berger
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  In vitro assessment of the relationship between acoustic properties and bone mass density of the calcaneus by comparison of ultrasound parametric imaging and quantitative computed tomography.

Authors:  P Laugier; P Droin; A M Laval-Jeantet; G Berger
Journal:  Bone       Date:  1997-02       Impact factor: 4.398

5.  Comparison of speed of sound and ultrasound attenuation in the os calcis to bone density of the radius, femur and lumbar spine.

Authors:  P Rossman; J Zagzebski; C Mesina; J Sorenson; R Mazess
Journal:  Clin Phys Physiol Meas       Date:  1989-11

6.  Frequency-dependent ultrasonic differentiation of normal and diffusely diseased liver.

Authors:  T Lin; J Ophir; G Potter
Journal:  J Acoust Soc Am       Date:  1987-10       Impact factor: 1.840

7.  The measurement of broadband ultrasonic attenuation in cancellous bone.

Authors:  C M Langton; S B Palmer; R W Porter
Journal:  Eng Med       Date:  1984-04

8.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

9.  In-vivo measurements of ultrasound attenuation in normal or diseased liver.

Authors:  K J Parker; M S Asztely; R M Lerner; E A Schenk; R C Waag
Journal:  Ultrasound Med Biol       Date:  1988       Impact factor: 2.998

10.  The effects of frequency-dependent attenuation and dispersion on sound speed measurements: applications in human trabecular bone.

Authors:  K A Wear
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2000       Impact factor: 3.267

View more
  21 in total

1.  Relationships among calcaneal backscatter, attenuation, sound speed, hip bone mineral density, and age in normal adult women.

Authors:  K A Wear; D W Armstrong
Journal:  J Acoust Soc Am       Date:  2001-07       Impact factor: 1.840

2.  The effect of phase cancellation on estimates of broadband ultrasound attenuation and backscatter coefficient in human calcaneus in vitro.

Authors:  Keith A Wear
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2008-02       Impact factor: 2.725

3.  The effect of phase cancellation on estimates of calcaneal broadband ultrasound attenuation in vivo.

Authors:  Keith A Wear
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2007-07       Impact factor: 2.725

4.  Characterization of the trabecular bone structure using frequency modulated ultrasound pulse.

Authors:  Wei Lin; Yi Xia; Yi-Xian Qin
Journal:  J Acoust Soc Am       Date:  2009-06       Impact factor: 1.840

5.  Lower Bound on Estimation Variance of the Ultrasonic Attenuation Coefficient Using the Spectral-Difference Reference-phantom Method.

Authors:  Kayvan Samimi; Tomy Varghese
Journal:  Ultrason Imaging       Date:  2016-10-20       Impact factor: 1.578

6.  Ultrasonic attenuation estimation of the pregnant cervix: a preliminary report.

Authors:  B L McFarlin; T A Bigelow; Y Laybed; W D O'Brien; M L Oelze; J S Abramowicz
Journal:  Ultrasound Obstet Gynecol       Date:  2010-08       Impact factor: 7.299

7.  Cancellous bone fast and slow waves obtained with Bayesian probability theory correlate with porosity from computed tomography.

Authors:  Joseph J Hoffman; Amber M Nelson; Mark R Holland; James G Miller
Journal:  J Acoust Soc Am       Date:  2012-09       Impact factor: 1.840

8.  Effects of phase cancellation and receiver aperture size on broadband ultrasonic attenuation for trabecular bone in vitro.

Authors:  Jiqi Cheng; Frederick Serra-Hsu; Yuan Tian; Wei Lin; Yi-Xian Qin
Journal:  Ultrasound Med Biol       Date:  2011-10-26       Impact factor: 2.998

Review 9.  Mechanisms of Interaction of Ultrasound With Cancellous Bone: A Review.

Authors:  Keith A Wear
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2019-10-16       Impact factor: 2.725

10.  Frequency specific ultrasound attenuation is sensitive to trabecular bone structure.

Authors:  Wei Lin; Frederick Serra-Hsu; Jiqi Cheng; Yi-Xian Qin
Journal:  Ultrasound Med Biol       Date:  2012-09-10       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.